Trending Now
Evofem Biosciences, Inc. (NASDAQ: EVFM) Collaborates with Emmy® Award-winning actress Annie...
Women should call the shots when it comes to their bodies, including making decisions on their quality of life and, more particularly, birth control...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Senti Biosciences (SNTI) Secures $8 Million Grant to Advance Groundbreaking Cancer...
In a significant advancement for cancer therapy, Senti Biosciences, Inc. (NASDAQ: SNTI), commonly known as Senti Bio, has received an $8...
MAKE IT MODERN
LATEST REVIEWS
GameStop (NYSE:GME) shorts could to be crushed by Apes
GameStop (NYSE:GME) reported a surprise profit in the fiscal fourth quarter, with earnings of 16 cents a share compared to a loss...
MAKE IT MODERN
PERFORMANCE TRAINING
Fresh Opportunities in Focus as Pot Stocks Launch on Legalization Potential (TLRY, SGMD, ACB,...
Cannabis stocks have been on the move again over the past two weeks for a very simple reason: The U.S. House of...
Stocks for the Pandemic Long Haul (FLGT, ALST, HOLX)
Scientists are beginning to arrive at the notion that the fight with Covid-19 is not a short raging battle that will be...
Sorrento Therapeutics Inc. (NASDAQ: SRNE) Releases Preliminary Phase 2 Abivertinib Study Results For Hospitalized...
Sorrento Therapeutics Inc. (NASDAQ: SRNE) has announced top-line interim findings from two-second phase studies meant to identify hospitalized patients with COVID-19 induced pneumonia and...
Menlo Therapeutics Inc (NASDAQ:MNLO) Reports Positive Data From Phase 2 Clinical Study Of FCD...
Menlo Therapeutics Inc (NASDAQ:MNLO) achieved a breakthrough to cure moderate to severe acne vulgaris. It is evident from positive data reported in Phase 2...
Apple Inc (NASDAQ:AAPL) is heading towards 300 and here’s why
China easing triggered a rally in the market today. I think AAPL probably wants $300 so I might be a little early...
MAKE IT MODERN
